Sickle Cell Anemia (DBCOND0028117)

Identifiers

Synonyms
Sickle-Cell Anaemia / Anaemia, Sickle Cell / Sickle Cell Anaemia / Sickle-cell anemia / Anemia, Sickle Cell / Sickle cell anemia / Sickle-cell disease without crisis / Sickle cell disease / Sickle-cell anemia, unspecified / Sickle-cell anaemia, unspecified / Sickle-cell disorders / Sickle cell disorders / Anaemia sickle cell / Sickle cell disease NOS / Sickling disorder due to hemoglobin S (disorder) / Sickle cell-hemoglobin SS disease (disorder) / Anemia sickle cell

Associated Data

Indicated Drugs and Targets
DrugDescriptionTargets
Hydroxyurea
An antimetabolite used to treat sickle cell anemia crisis, resistant chronic myeloid leukemia, and Locally advanced squamous cell carcinomas of the head and neck (excluding the lip).
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT05681598
Hydroxyurea Treatment for Adult Sickle Cell Anemia Patients in KinshasaNo drug interventionstreatmentNot Availablecompleted
NCT05660265
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Oral GSK4172239D Compared With Placebo in Sickle Cell Disease Participants Aged 18 to 50 YearsNo drug interventionstreatment1recruiting
NCT05087303
Telemedicine for Children With Sickle Cell DiseaseNo drug interventionshealth_services_researchNot Availablerecruiting
NCT02187003
Efficacy and Safety of Rivipansel (GMI-1070) in the Treatment of Vaso-Occlusive Crisis in Hospitalized Subjects With Sickle Cell DiseaseNo drug interventionstreatment3completed
NCT00005703
Hemostasis in Sickle Cell Disease--Infancy to AdulthoodNo drug interventionsNot AvailableNot Availablecompleted
NCT01566890
Microvascular Blood Flow in Sickle Cell AnemiaNo drug interventionsdiagnosticNot Availablecompleted
NCT05457790
Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)No drug interventionssupportive_careNot Availablerecruiting
NCT02675790
Moderate Dose Hydroxyurea for Secondary Stroke Prevention in Children With Sickle Cell Disease in Sub-Saharan AfricaNo drug interventionsprevention3completed
NCT00538564
Tadalafil for Treatment of Priapism in Men With Sickle Cell AnemiaNo drug interventionsprevention2withdrawn
NCT00512564
Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell ThalassemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT01137721
State Of The Art Functional Imaging In Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00456443
Invasive Infections in Children With HemoglobinopathiesNo drug interventionsNot AvailableNot Availablecompleted
NCT00004143
Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure SyndromesNo drug interventionstreatment2completed
NCT00094887
Nitric Oxide Inhalation to Treat Sickle Cell Pain CrisesNo drug interventionstreatment2completed
NCT02394587
MBSR for Pain Catastrophizing in SCDNo drug interventionssupportive_careNot Availablecompleted
NCT04400487
Actigraphy Improvement With Voxelotor (ActIVe) Studytreatment4completed
NCT01531387
Sparing Conversion to Abnormal TCD (Transcranial Doppler) Elevation (SCATE)prevention3terminated
NCT02636387
Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell DiseaseNot AvailableNot Availableterminated
NCT00360087
A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET StudyNo drug interventionstreatment3terminated
NCT00056433
Evaluation of Hydroxyurea Plus L-arginine or Sildenafil to Treat Sickle Cell AnemiaNo drug interventionstreatment1completed
NCT03380351
Specifying Interventions From the Sickle Cell Disease Implementation Consortium (SCDIC)No drug interventionsNot AvailableNot Availablecompleted
NCT04476277
Red Cell Half Life Determination in Patients With and Without Sickle Cell Diseasebasic_science0completed
NCT02372877
Evaluation of the AMICUS RBCx System in Sickle Cell PatientsNo drug interventionstreatmentNot Availablecompleted
NCT02843347
STRIDE BiorepositoryNo drug interventionsNot AvailableNot Availableunknown_status
NCT04351698
SMILES: Study of Montelukast in Sickle Cell Diseasetreatment2 / 3recruiting
NCT02990598
Hydoxyurea Exposure in Lactation A Pharmacokinetics Study (HELPS)No drug interventionsNot AvailableNot Availablecompleted
NCT00004797
Pilot Study of Fructose for Sickle Cell CrisisNo drug interventionstreatmentNot Availablecompleted
NCT02326597
Decision Aid for Therapeutic Options In Sickle Cell DiseaseNo drug interventionshealth_services_researchNot Availablecompleted
NCT00072761
Silent Cerebral Infarct Transfusion Multi-Center Clinical TrialNo drug interventionstreatment3completed
NCT00034528
Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or ThalassemiaNo drug interventionstreatment2terminated
NCT00236093
Extension Study of ACTIQ Treatment for Children and Adolescents With Breakthrough PainNo drug interventionstreatment2completed
NCT00059293
Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUGNo drug interventionsNot AvailableNot Availablecompleted
NCT00037388
Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP IINo drug interventionsNot AvailableNot Availablecompleted
NCT00735488
Sickle Cell Anemia Screening and Prevention in Northern IsraelNo drug interventionsNot AvailableNot Availablecompleted
NCT00125788
L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 ThalassemiaNo drug interventionstreatment2completed
NCT01425307
Transcranial Doppler (TCD) With Transfusions Changing to Hydroxyureaprevention3terminated
NCT04800809
The Afolabi Stroke Registry for Children and Young Adults With SCD in Northern NigeriaNo drug interventionsNot AvailableNot Availablecompleted
NCT00586209
L-Glutamine Therapy for Sickle Cell Anemiatreatment2terminated
NCT04420585
Desmopressin for Bedwetting in Children With SCDtreatment4terminated
NCT00004485
Bone Marrow Transplantation in Treating Children With Sickle Cell DiseaseNo drug interventionstreatment1 / 2completed
NCT03128515
Optimizing Hydroxyurea Therapy in Children With SCA In Malaria Endemic Areastreatment3completed
NCT02657837
Measures of Respiratory Health (MRH)No drug interventionsNot AvailableNot Availablerecruiting
NCT03114137
Heart Arteries and Sickle Cell Disease / Coeur Artères DREpanocytoseNo drug interventionsNot AvailableNot Availableunknown_status
NCT01350232
Treatment of Sickle Cell Anemia With Stem Cell TransplanttreatmentNot Availableterminated
NCT04255875
Dose Escalation Study of PF-07209326 in Healthy Participants and Participants With Sickle Cell DiseaseNo drug interventionsbasic_science1completed
NCT01441375
Sickle Cell Disease: A Retrospective Chart ReviewNo drug interventionsNot AvailableNot Availablecompleted
NCT00981370
Clinical Importance of Treating Iron Overload in Sickle Cell Diseasetreatment3terminated
NCT01758042
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood DisordersNo drug interventionstreatmentNot Availablerecruiting
NCT02530242
Carbon Monoxide Measurement to Screen for Sickle Cell DiseaseNo drug interventionsdiagnosticNot Availablecompleted
NCT01178099
An Assessment of Prasugrel on Healthy Adults and Sickle Cell Adultsbasic_science1completed
NCT02556099
EXTEND EXpanding Treatment for Existing Neurological Diseasetreatment2active_not_recruiting
NCT06144749
A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Subjects With Sickle Cell Disease (SCD)No drug interventionstreatment1 / 2not_yet_recruiting
NCT05675436
Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT04406818
Metabolic and Hemodynamic Reserve in Pediatric SCAbasic_scienceNot Availablerecruiting
NCT03006718
SCD-PROMIS: A Software Platform to Enhance Self-efficacy and Patient-provider Engagement for Patients With Sickle Cell PainNo drug interventionsotherNot Availablecompleted
NCT00850018
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell Disease - Pilot Intervention StudyNo drug interventionstreatment1completed
NCT03926819
A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy VolunteersNo drug interventionstreatment1completed
NCT02373241
Preventing Sickle Cell Kidney Diseasetreatment2terminated
NCT06016634
Alendronate for Osteonecrosis in Adults With Sickle Cell Diseasetreatment2recruiting
NCT01976416
Novel Use Of Hydroxyurea in an African Region With Malariatreatment3completed
NCT02090296
Risk-based Therapy for Sickle Cell Anemia: A Feasibility Studyprevention2withdrawn
NCT00890396
Long-Term Effects of Hydroxyurea in Children With Sickle Cell Anemia (The BABY HUG Follow-up Study)Not AvailableNot Availablecompleted
NCT00023296
Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary HypertensionNo drug interventionstreatment1completed
NCT02065596
Hematopoietic Stem Cell Transplant for Sickle Cell Diseasetreatment1completed
NCT02433158
Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Diseasetreatment3terminated
NCT00578435
Allogeneic Bone Marrow Transplantation for the Treatment of Genetic Disorders of ErythropoiesisNo drug interventionstreatment2completed
NCT00035763
Pain in Sickle Cell Epidemiologic StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT00313963
MAST - Magnesium for Sickle Cell Acute Crisis in ChildrenNo drug interventionstreatment3completed
NCT01479439
Losartan to Reverse Sickle Nephropathytreatment2completed
NCT00542230
Blood Sampling for Research Related to Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT05283148
Sickle Cell Disease (SCD) Bone Pain StudyNo drug interventionsdiagnosticNot Availablecompleted
NCT04170348
Daily Vitamin D for Sickle-cell Respiratory Complicationsprevention2active_not_recruiting
NCT02467257
Gum Arabic as Fetal Hemoglobin Agent in Sickle Cell AnemiaNo drug interventionstreatment1 / 2completed
NCT00512226
Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell ThalassemiaNo drug interventionsdiagnosticNot Availablecompleted
NCT01589926
Bi-Level Positive Airway Ventilation for Acute Chest SyndromeNo drug interventionssupportive_careNot Availableterminated
NCT01800526
A Pilot Study of N-acetylcysteine in Patients With Sickle Cell Diseasetreatment1 / 2completed
NCT00600665
Effectiveness of a Computerized Tool (PAINRelieveIt) to Help Manage Pain Related to Sickle Cell DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT00399074
Sulfadoxine- Pyrimethamine Versus Weekly Chloroquine for Malaria Prevention in Children With Sickle Cell AnemiaNo drug interventionsprevention3completed
NCT00599482
Far Infrared Radiation for Sickle Cell Pain ManagementNo drug interventionssupportive_care1unknown_status
NCT00783627
Sickle Cell Disease and Endothelial Progenitor Cells (EPCs)No drug interventionsNot AvailableNot Availablecompleted
NCT00005327
Prevention of Cerebral Infarction in Sickle Cell Anemia - Comprehensive Sickle Cell CenterNo drug interventionsNot AvailableNot Availablecompleted
NCT01558076
Longitudinal Changes in Exercise Capacity in Children and Young Adults With Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availableunknown_status
NCT00736060
Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With FeverNo drug interventionsNot AvailableNot Availablecompleted
NCT01848691
Carbon Monoxide Monitor for the Measurement of End-Tidal Carbon Monoxide Levels in Children With or Without HemolysisNo drug interventionsdiagnosticNot Availablecompleted
NCT02022891
Systematic Psychological and Medical Care for Children With SCDNo drug interventionsNot AvailableNot Availablecompleted
NCT01482091
Intranasal Fentanyl for Initial Treatment of a Vaso-occlusive Crisistreatment4completed
NCT00122980
Stroke With Transfusions Changing to HydroxyureaNo drug interventionsprevention3terminated
NCT00029380
Cord Blood Transplantation for Sickle Cell Anemia and ThalassemiaNo drug interventionstreatment2completed
NCT05169580
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FTX-6058No drug interventionstreatment1recruiting
NCT00067080
Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood TransfusionsNo drug interventionstreatment2completed
NCT04208529
A Long-term Follow-up Study in Participants Who Received CTX001other3enrolling_by_invitation
NCT02981329
Fetal Hemoglobin Induction Treatment Metformintreatment0completed
NCT00000592
Stroke Prevention in Sickle Cell Anemia (STOP 1)No drug interventionsprevention3completed
NCT04705792
Physical Rehabilitation in Sickle Cell AnemiaNo drug interventionstreatmentNot Availableunknown_status
NCT04536792
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AG-946 in Healthy Volunteers and in Participants With Sickle Cell DiseaseNo drug interventionstreatment1completed
NCT00937144
Endothelial Function in Patients With Sickle Cell Anemia Before and After SildenafilNo drug interventionstreatment4withdrawn
NCT00618644
Ranibizumab for Neovascularization in Sickle Cell RetinopathyNo drug interventionstreatmentNot Availablewithdrawn
NCT01601340
Effects of HQK-1001 in Patients With Sickle Cell DiseaseNo drug interventionstreatment2terminated
NCT02672540
A Study of SANGUINATE for the Treatment of Vaso-occlusive Crisis (VOC) in Adult Sickle Cell Disease PatientsNo drug interventionstreatment2completed
NCT00735540
Clinical Diagnosis of Teenagers Admitted to Pediatric DepartmentsNo drug interventionsNot AvailableNot Availablecompleted
NCT00519701
Hydroxyurea in Young Children With Sickle Cell AnemiaNo drug interventionspreventionNot Availablecompleted
NCT01419704
Phase I/II Pilot Study of Mixed Chimerism to Treat HemoglobinopathiesNo drug interventionstreatment1 / 2withdrawn
NCT00004404
Study of Clotrimazole and Hydroxyurea in Patients With Sickle Cell SyndromesNo drug interventionstreatmentNot Availablecompleted
NCT02065869
Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell TransplantNo drug interventionstreatment1 / 2terminated
NCT00276146
Dipyridamole/Magnesium To Improve Sickle Cell HydrationNo drug interventionsNot Available2withdrawn
NCT02712346
The Role of Endothelin-1 in Sickle Cell DiseaseNo drug interventionstreatment1completed
NCT00948012
Exercise-induced Pulmonary Hypertension in Patients With Sickle-cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00004412
Phase II Randomized Trial:Arginine Butyrate Plus Standard Local Therapy in Patients With Refractory Sickle Cell UlcersNo drug interventionstreatment2completed
NCT04201210
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCDNo drug interventionstreatment2recruiting
NCT00009581
Nitric Oxide to Improve Blood Flow in Sickle Cell DiseaseNo drug interventionstreatment2completed
NCT06250595
European Rare Blood Disorders Platform (ENROL)No drug interventionsNot AvailableNot Availablerecruiting
NCT01801423
Sickle Cell Disease - Stroke Prevention in Nigeria TrialNo drug interventionstreatmentNot Availablecompleted
NCT00005438
Neuropsychological Studies of Children With Sickle CellNo drug interventionsNot AvailableNot Availablecompleted
NCT03653338
T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other AnemiasNo drug interventionstreatment1 / 2recruiting
NCT00495638
Pulmonary Hypertension, Hypoxia and Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT05347043
The Montreal Cognitive Assessment.Test in Adults With Sickle Cell DiseaseNo drug interventionsscreeningNot Availableunknown_status
NCT00528203
Establishing a Repository of Blood and DNA Samples From People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Genotype-Phenotype Database and Sample Repository)No drug interventionsNot AvailableNot Availableterminated
NCT01783990
Pediatric Hydroxyurea Phase III Clinical Trial (BABY HUG) Follow-up Observational Study II ProtocolNo drug interventionsNot AvailableNot Availablecompleted
NCT00000602
Pediatric Hydroxyurea in Sickle Cell Anemia (PED HUG)No drug interventionstreatment2completed
NCT01905787
Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter StudyNo drug interventionsNot AvailableNot Availableunknown_status
NCT02286154
Therapeutic Response Evaluation and Adherence Trial (TREAT)No drug interventionstreatmentNot Availablerecruiting
NCT00040677
A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia.No drug interventionstreatment2completed
NCT00246077
Quality of Life of Children With Sickle Cell Disease Who Are Getting Chronic Transfusions With a LifeportNo drug interventionsNot AvailableNot Availablecompleted
NCT00005277
Cooperative Study of The Clinical Course of Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01522547
Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sickle Cell DiseaseNo drug interventionstreatment1completed
NCT04011345
Folic Acid Supplementation in Children With Sickle Cell DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT02769845
SACRED A Prospective Research Study to Reduce Stroke in Children With Sickle Cell AnemiaNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT00971698
The Spleen in Sickle Cell Anemia and Sickle Cell ThalassemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00669305
Bone Marrow for Hemoglobinopathy ResearchNo drug interventionsNot AvailableNot Availablecompleted
NCT02258997
Hepcidin Levels in Sickle Cell Disease (SCD)No drug interventionsNot AvailableNot Availablecompleted
NCT00001197
Hydroxyurea for the Treatment of Patients With Sickle Cell AnemiaNo drug interventionstreatment2completed
NCT00005783
A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling DisordersNo drug interventionstreatment1completed
NCT00529061
Establishing a Database of People With Sickle Cell Disease (Comprehensive Sickle Cell Centers Collaborative Data Project [C-Data])No drug interventionsNot AvailableNot Availableterminated
NCT04584528
Implementing an Individualized Pain Plan (IPP) for ED Treatment of VOE's in Sickle Cell DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT00029393
Induction of Stable Chimerism for Sickle Cell AnemiaNo drug interventionstreatment2completed
NCT00005893
Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic DisordersNo drug interventionstreatmentNot Availablecompleted
NCT01783093
Tricuspid Regurgitant Jet Velocity as an Independent Marker for Mortality in Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT01547793
Carbon Monoxide Levels and Sickle Cell Disease SeverityNo drug interventionsNot AvailableNot Availablecompleted
NCT03376893
Epidemiology of Silent and Overt Strokes in Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT04808778
Stroke Prevention in Young Adults With Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03634488
Management of Severe Acute Malnutrition in SCD, in Northern NigeriaNo drug interventionstreatment2completed
NCT04001907
Effect of Exercise With and Without HMB on Body Composition and Muscle Strength in Sickle Cell AnaemiaNo drug interventionstreatmentNot Availableunknown_status
NCT04581356
Voxelotor Sickle Cell Exercise StudyNo drug interventionstreatment4completed
NCT01356485
Safety Study of MP4CO in Adult Sickle Cell PatientsNo drug interventionsNot Available1completed
NCT00000585
Penicillin Prophylaxis in Sickle Cell Disease (PROPS)No drug interventionsprevention3completed
NCT03020615
Hydroxyurea Management in Kids: Intensive Versus Stable Dosage StrategiesNo drug interventionstreatment2completed
NCT02149537
Risk Clinical Stratification of Sickle Cell Disease in Nigeria, Assessment of Efficacy/Safety of Hydroxyurea TreatmentNo drug interventionstreatment4completed
NCT04091737
CSL200 Gene Therapy in Adults With Severe Sickle Cell DiseaseNo drug interventionstreatment1terminated
NCT00113152
Heart Disease in Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00006400
Hydroxyurea to Prevent Organ Damage in Children With Sickle Cell AnemiaNo drug interventionsprevention3completed
NCT00005300
Investigation of Selected Patient Groups From The Cooperative Study of Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00448370
Role of Placenta Growth Factor in Sickle Acute Chest SyndromeNo drug interventionsNot AvailableNot Availablecompleted
NCT00530270
Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell DiseaseNo drug interventionstreatment3terminated
NCT01527799
Exercise Capacity in Pediatric Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT04134299
To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell DiseaseNo drug interventionsbasic_scienceNot Availablecompleted
NCT06481306
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell DiseaseNo drug interventionstreatment1 / 2recruiting
NCT02565849
Study of Ventilatory Mechanics in Patients With Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT03733249
Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical StudyNo drug interventionstreatment1 / 2terminated
NCT00115336
Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell DiseaseNo drug interventionstreatment4terminated
NCT02186418
Gene Transfer for Patients With Sickle Cell DiseaseNo drug interventionssupportive_care1 / 2terminated
NCT02961218
Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Pediatric and Young Adult Patients With Sickle Cell AnemiaNo drug interventionstreatment2completed
NCT00294541
A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea TherapyNo drug interventionstreatment3terminated
NCT00040417
Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk HemoglobinopathiesNo drug interventionstreatment2terminated
NCT00513617
Effectiveness of Arginine as a Treatment for Sickle Cell AnemiaNo drug interventionstreatment2completed
NCT03397017
Transfusion Treatment in Patients With SCDNo drug interventionsNot AvailableNot Availablecompleted
NCT01179217
A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemiaNo drug interventionstreatment3completed
NCT02497924
A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male SubjectsNo drug interventionsother1completed
NCT00001716
Effects of Nitric Oxide and Nitroglycerin in Patients With Sickle Cell AnemiaNo drug interventionstreatment2completed
NCT06078696
Siplizumab for Sickle Cell Disease TransplantNo drug interventionstreatment1 / 2recruiting
NCT01316796
Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood DisordersNo drug interventionstreatment1completed
NCT06503458
A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell ParticipantsNo drug interventionsNot AvailableNot Availableterminated
NCT00300235
Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and PrevalenceNo drug interventionsNot AvailableNot Availablecompleted
NCT05477563
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell DiseaseNo drug interventionstreatment3recruiting
NCT00000586
Multicenter Study of Hydroxyurea in Patients With Sickle Cell Anemia (MSH)No drug interventionstreatment3completed
NCT04093986
Hydroxyurea Exposure Limiting Pregnancy and Follow-Up LactationNo drug interventionsNot AvailableNot Availablerecruiting
NCT02162225
Study of Beet Juice for Patients With Sickle Cell AnemiaNo drug interventionstreatment2withdrawn
NCT00006130
Decompression Coring Versus Conservative Therapy in Patients With Avascular Necrosis of the Hip Related to Sickle Cell DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT03069430
A Self-Management Intervention for Youth With Sickle Cell Disease and Their Families: Phase INo drug interventionsNot AvailableNot Availablecompleted
NCT00011648
Secondary Pulmonary Hypertension in Adults With Sickle Cell AnemiaNo drug interventionsNot AvailableNot Availablecompleted
NCT00005326
Cerebrovascular Involvement in Sickle Cell Disease - Comprehensive Sickle Cell CenterNo drug interventionsNot AvailableNot Availablecompleted
NCT00480974
Long Term Follow up in Sickle Cell Patients Treated by HydroxyureaNo drug interventionsNot AvailableNot Availablecompleted
NCT06529874
Pressure Pain Tolerance in Relation to Balance and Strength in ChildrenNo drug interventionsotherNot Availablerecruiting
NCT00006182
Stroke Prevention in Sickle Cell Anemia (STOP 2)No drug interventionsprevention3completed
NCT00860782
Parent Educational Program for Children With Sickle Cell DiseaseNo drug interventionssupportive_careNot Availablecompleted
NCT05357482
Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease and Beta-ThalassemiaNo drug interventionstreatment1 / 2recruiting
NCT00029731
Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease PatientsNo drug interventionstreatment2completed
NCT03249831
A Blood Stem Cell Transplant for Sickle Cell DiseaseNo drug interventionstreatment1active_not_recruiting
NCT01788631
A Phase II Trial of Regadenoson in Sickle Cell AnemiaNo drug interventionstreatment2completed
NCT01894594
Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell DiseaseNo drug interventionstreatment1terminated
NCT03789591
Hydroxyurea Optimization Through Precision StudyNo drug interventionsprevention3recruiting
NCT00977691
Haploidentical PBMC Transplant for Severe Congenital AnemiasNo drug interventionstreatment1 / 2active_not_recruiting
NCT00971880
Blood Transfusions in Thalassemia Patients, Complications and Adverse EffectsNo drug interventionsNot AvailableNot Availablecompleted
NCT02813629
tDCS Associated With Peripheral Electrical Stimulation for Pain Control in Individuals With Sickle Cell DiseaseNo drug interventionstreatment2unknown_status
NCT00672789
Adherence to Hydroxyurea in Children With Sickle Cell AnemiaNo drug interventionshealth_services_researchNot Availablecompleted
NCT00004492
Phase I/II Randomized Study of Hydroxyurea With or Without Clotrimazole in Patients With Sickle Cell AnemiaNo drug interventionstreatment1 / 2completed
NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsNo drug interventionsNot AvailableNot Availablecompleted
NCT02445144
Establishment of Functional MRI Imaging Parameters for Use in the Evaluation of Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availableterminated
NCT01506544
Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell AnemiaNo drug interventionsNot Available1completed
NCT05451940
Hydroxyurea and EPO in Sickle Cell DiseaseNo drug interventionstreatment1 / 2recruiting
NCT00005467
Indices of Severity and Prognosis for Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT00840567
Skin and Blood Research Samples From Healthy Volunteers and Patients With Hematologic DiseasesNo drug interventionsbasic_scienceNot Availableterminated
NCT03062501
Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell CrisisNo drug interventionstreatment2unknown_status
NCT00528801
Examining Cognitive Function and Brain Abnormalities in Adults With Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availablecompleted
NCT01925001
Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle CrisisNo drug interventionstreatment2withdrawn
NCT06290401
A Socio-ecological Approach for Improving Self-management in Adolescents With SCDNo drug interventionstreatment2not_yet_recruiting
NCT01703104
The Efficacy of Jobelyn (Sorghum Bicolor Extract)in the Treatment of Sickle Cell AnemiaNo drug interventionstreatment1 / 2completed
NCT01340404
Allogeneic Genoidentical Stem Cell Transplantation in Children With Sickle-cell Anemia and Cerebral VasculopathyNo drug interventionstreatmentNot Availablecompleted
NCT00874172
Effectiveness of New Analgesic Strategy Compared to the Usal Antalgic StrategyNo drug interventionstreatmentNot Availablecompleted
NCT00143572
Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell DiseaseNo drug interventionstreatment1completed
NCT00095472
Therapeutic Application of Intravascular Nitrite for Sickle Cell DiseaseNo drug interventionstreatment1completed
NCT02072668
The Effect of Rivaroxaban in Sickle Cell DiseaseNo drug interventionstreatment2completed
NCT01054768
Antioxidant Therapy to Reduce Inflammation in Sickle Cell DiseaseNo drug interventionstreatment2completed
NCT01092169
Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-ThalassemiaNo drug interventionsNot AvailableNot Availableunknown_status
NCT01322269
A Study of HQK-1001 in Patients With Sickle Cell DiseaseNo drug interventionstreatment2completed
NCT00040469
Bone Marrow Transplant From Related Donor for Patients With High Risk HemoglobinopathiesNo drug interventionstreatment2terminated
NCT02561312
Comparison of Two Methods of Transfusion for Stroke Prevention in Sickle CellNo drug interventionsNot AvailableNot Availablecompleted
NCT03442114
Shared-Decision Making for HydroxyureaNo drug interventionshealth_services_researchNot Availableunknown_status
NCT01000155
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell DiseaseNo drug interventionstreatment2terminated
NCT01167023
Prasugrel Versus Placebo in Adult Sickle Cell DiseaseNo drug interventionstreatment2completed
NCT02857023
Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell DiseaseNo drug interventionstreatmentNot Availablecompleted
NCT02411708
Study of SANGUINATE™ In the Treatment of Sickle Cell Disease Patients With Vaso-Occlusive CrisisNo drug interventionstreatment2completed
NCT00131508
Trial of Oral Glutamine in Patients With Sickle Cell AnemiaNo drug interventionsprevention2terminated
NCT00004408
Phase III Randomized Study of Poloxamer 188 for Vaso-Occlusive Crisis of Sickle Cell DiseaseNo drug interventionstreatment3completed
NCT02004808
Neutrophil Extracellular Traps and Sickle Cell DiseaseNo drug interventionsNot AvailableNot Availableunknown_status
NCT00415727
Prevention Of Morbidity In Sickle Cell Disease Pilot PhaseNo drug interventionsNot Available2unknown_status
NCT02844673
Mobile-Directly Observed Therapy on Adherence to HydroxyureaNo drug interventionstreatment2completed